Blog Posts
CURE ID
FDA Oncology/X

FDA Oncology Highlights CURE ID for Sharing Off-Label Treatment Experiences in Rare Cancer

FDA Oncology shared a post on X:

“Physicians – Your off-label treatment experiences – both successes and failures – could help others. CURE ID makes it easy to share rare cancer cases on a trusted platform – hosted by US FDA and NIH, NCATS.
Start now.”

More posts featuring FDA Oncology on OcnoDaily.

cancer FDA Oncology NCATS NIH OncoDaily Oncology Rare Cancer Cases Rare Cancers